CALLIDITAS THERAPEUTICS AB's ticker is CALT and the CUSIP is 13124Q106. A total of 18 filers reported holding CALLIDITAS THERAPEUTICS AB in Q3 2023. The put-call ratio across all filers is 10.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $216,618 | – | 11,863 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 200,000 | $6,724,000 | 2.33% |
| BVF INC/IL | 750,000 | $25,493,000 | 1.00% |
| Logos Global Management LP | 300,000 | $10,086,000 | 0.86% |
| Vivo Capital, LLC | 311,030 | $10,457,000 | 0.47% |
| HHLR ADVISORS, LTD. | 1,047,687 | $35,611,000 | 0.28% |
| Pentwater Capital Management LP | 50,000 | $1,681,000 | 0.02% |
| Point72 Asset Management, L.P. | 102,748 | $3,454,000 | 0.02% |
| DEUTSCHE BANK AG\ | 70,236 | $2,361,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 20,484 | $696,000 | 0.00% |
| JANE STREET GROUP, LLC | 7,557 | $256,000 | 0.00% |